TLX News: Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix® - 17th Sep 2024, 9:00pm

annb0t

Top 20
Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as a commercial radiopharmaceutical distributor to supply finished unit doses of its PET1 agent, Zircaix®2 (TLX250-CDx) for the imaging of kidney cancer in the United States (U.S.), subject to regulatory approval.

In preparation for a planned commercial rollo...

>>> Read more: Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
 
Top Bottom